12-lead ECG has limited ability to detect increased left ventricular (LV)
mass, we have recently demonstrated that electrocardiographic left ventricular hypertrophy (LVH) by Sokolow-Lyon voltage criteria was associated with SCA independent of anatomic LVH (Narayanan et al., 2014) . Therefore, adverse electrical LV remodeling in the absence of anatomic remodeling is emerging as a potentially distinct phenomenon from anatomic LV hypertrophy .
The Romhilt-Estes point score system (RE score) was first presented in 1968 as a new method for diagnosing LVH on the ECG (Romhilt & Estes, 1968) . In contrast with traditional voltage-based LVH criteria, the RE score takes into account multiple ECG abnormalities.
It is made up of nine individual criteria determined from the 12-lead ECG, with RE score of 4 being labeled as probable LVH and a score of 5 or greater as definite LVH (Romhilt & Estes, 1968) . In addition to diagnosing LVH, the RE score has been shown to predict adverse cardiovascular events and all-cause mortality (Estes, Zhang, Li, Tereschenko, & Soliman, 2015; Estes, Zhang, Li, Tereshchenko, & Soliman, 2015) , and we recently demonstrated that one component of the RE score, delayed intrinsicoid deflection, was independently predictive of SCA (Darouian et al., 2016) . However, little data exists on the performance of the other individual components, or the RE score as a whole as a predictor of SCA. In this study, we explored the association of RE score and its individual components with SCA, and compared it to other traditional voltage-based LVH criteria. Moreover, we studied whether this association with SCA was independent of increased left ventricular mass.
| METHODS

| Ascertainment of subjects
This study was approved by the institutional review boards of CedarsSinai Medical Center, Oregon Health and Science University, and all other relevant health systems.
We evaluated the relationship of the RE score and SCA from the Oregon Sudden Unexpected Death Study (Oregon SUDS). The details of this ongoing study have been published previously (Chugh et al., 2009; Darouian et al., 2016; Narayanan et al., 2014; Teodorescu et al., 2001 ). Cases and controls in the study were enrolled from the Portland, Oregon metropolitan area consisting of a population of approximately one million individuals. SCA was defined as a sudden unexpected pulseless condition in witnessed individuals within 1 hr of symptom onset; and within 24 hr of last being seen in a normal state of health for unwitnessed cases. Cases with known terminal illnesses, traumatic deaths, drug overdoses, or other known noncardiac conditions were excluded. Cases of SCA were identified via emergency medical services, local hospitals, and the medical examiner's office, and then reviewed as part of an in-house adjudication process by three physicians prior to inclusion in the study. Control subjects recruited for this study had visited local cardiology clinics, were transported via EMS for symptoms concerning for cardiac ischemia, had undergone coronary angiography, or were members of a regional health maintenance organization. Since coronary artery disease (CAD) is responsible for most SCA cases, also majority of controls enrolled in this study had established CAD. CAD was defined as a history of a myocardial infarction, coronary revascularization, or ≥50% occlusion of a major coronary artery. Between February 1, 2002 and September 10, 2014, 3,020 SCA cases (mean age 62.7 years, 67.5% male) with medical records available were identified in the Oregon SUDS. A total of 682 of these subjects had an ECG performed prior to cardiac arrest, and following exclusion of those without an echocardiogram, and those with severe aortic stenosis, hypertrophic cardiomyopathy, and Wolff-ParkinsonWhite syndrome 272 cases and 351 controls remained. Individuals with left bundle branch block and paced rhythms were excluded, leaving 247 cases and 330 controls available for the analysis.
| ECG and echocardiographic analysis
All subjects enrolled in this study were required to have both ECG and echocardiographic information available for analysis. For cases of SCA, ECGs, and echocardiogram reports performed as part of routine clinical practice were obtained from patients' medical charts; if more than one was available, the test closest to the SCA event was selected for analysis. Twenty-nine survivors of SCA were also included in the analysis. For controls, ECG and echocardiographic data were obtained from patients' medical charts available prior to enrollment, as for cases. For controls, ECGs were also performed at time of enrollment in the study. Two trained physicians reviewed standard 12-lead ECG recordings at 25 mm/s paper speed and 10 mm/mV amplitude. Heart rate, QRS durations, and QRS axis were recorded as standard values from the ECG recording. Additional ECG waveforms, intrinsicoid deflection, left atrial abnormality, and strain were measured manually by a trained physician research (N.D.). An experienced cardiologist (A.A.) remeasured these manual recordings in a subset, to assess interobserver variability with a kappa value of .89.
We evaluated the presence of echocardiographic LVH using LV mass indices >134 g/m 2 in men and >110 g/m 2 in women (Devereux et al., 1984) . LV mass was calculated using the following formula:
3 )) + 0.6 g) (Devereux et al., 1984 ; LVIDD: left ventricular internal diameter in diastole, PWd: posterior wall thickness in diastole, IVSd: interventricular septal thickness in diastole). We then corrected for body surface area to obtain LV mass index values. Severe LV dysfunction was defined as left ventricular ejection fraction (LVEF) ≤35%.
| Electrocardiographic LVH
ECGs were measured for the components of the RE score as fol- Positive voltage criteria in limb leads, SV 1,2 , or RV 5,6 were awarded 3 points. ST changes consistent with strain were given 3 points in subjects not on digoxin and 1 point otherwise. The remainder of the findings was given the following scores: 3 points for left atrial abnormality, 2 points for left axis deviation, 1 point for QRS duration, 1 point for delayed intrinsicoid deflection. Probable LVH and definite LVH were defined as RE scores of 4 and ≥5, respectively (Romhilt & Estes, 1968) . Sokolow-Lyon LVH Criteria (SV 1 + RV 5,6 ≥ 35 mm) and
Cornell Criteria (RaVL + SV 3 ≥ 20 mm in females, ≥28 mm in males)
were measured in each ECG as well (McLenachan, Henderson, Morris, & Dargie, 1987; Sokolow & Lyon, 1949) .
| Statistical analysis
Case-control comparisons were performed using Pearson's chi-square tests and independent samples t-tests for categorical and quantitative variables, respectively. Multiple logistic regression models were used to perform multivariable analysis including variables found to be statistically significant in univariate analysis. We evaluated the agreement between the RE score and Echo LVH using the Kappa statistic.
Values were considered statistically significant when p ≤ .05. Data is presented as n (%) or mean ± SD.
| RESULTS
| Demographics
Cases of SCA (n = 247, age: 68.3 ± 14.6, male: 64.4%) were compared to controls (n = 330, age: 67.4 ± 11.5, male: 63.6%) as demonstrated in Table 1 . Cases were more likely to have a history of diabetes mellitus (49.4% vs. 33.0%, p < .001) than controls. Cases were also noted to have significantly higher resting heart rates than controls.
Echocardiographic findings of significance included lower ejection fractions (50.8% ± 15.7 vs. 54.9% ± 12.6, p = .001) and greater LV mass indices (120.3 g/m 2 ± 42.6 vs. 100.5 g/m 2 ± 32.5, p < .001) in cases than controls.
| RE score and anatomic left ventricular hypertrophy
Of the sample population, 440 subjects (76.3%) had no forms of LVH per RE score ( 
| RE score and SCA
RE scores were found to be significantly higher in cases than controls (2.5 ± 2.1 vs. 1.9 ± 1.7, p < .001). The probable LVH sub group with RE score of 4 did not demonstrate a statistically significant difference between cases and controls. However, an RE score of ≥5 was more prevalent in cases than controls (18.6% vs. 7.9%, p < .001), with the unadjusted risk of SCA being 2.7 (95% CI: 1.6-4.5, p < .001).
In a multivariable analysis with age, sex, hypertension, diabetes mellitus, severe LV dysfunction, and heart rate in the model, RE score ≥5 was associated with a significant risk of SCA (OR: 2.1, 95% CI: 1.2-3.6, p = .006; 
| Individual components of the RE score and SCA
As demonstrated in Table 4 , several of the individual components of the RE score were more predominant in cases of SCA than controls.
SV 1-2 ≥ 30 mm was present in 4.9% of cases as compared to 1.2% of controls (p = .008). ST segment changes consistent with "strain" pattern were more common in cases as well in individuals on and off digoxin. Left atrial abnormality (p = .044) and delayed intrinsicoid deflection (p = .003) were also found significantly more common in SCA as well.
We performed similar multivariable analysis with a model including age, sex, hypertension, diabetes mellitus, severe LV dysfunction, heart rate, and anatomic LVH with each of the RE score criteria added individually in this model. As demonstrated in Table 5 , only SV 1-2 ≥ 30 mm and delayed intrinsicoid deflection remained independent predictors of SCA with echo-derived LVH in the model.
| Comparison of RE score with other LVH criteria
In comparison to the other well-established electrocardiographic LVH criteria, Sokolow-Lyon and Cornell criteria, definite LVH as determined by the RE score ≥5 carried the greatest risk of SCA (Figure 1 ). 
| ECG LVH and intraventricular conduction delays
In a subgroup of patients, all subjects with QRS duration ≥120 ms were excluded from the analysis to evaluate whether any significant conduction delay would affect the findings. 
| DISCUSSION
There is emerging evidence suggesting that electrocardiographic LVH is a risk factor for SCA independent of increased LV mass . In this study, we evaluated this relationship using the Romhilt-Estes point score system as the criterion for diagnosis of electrocardiographic LVH. Our results demonstrate a significant association with definite LVH, or RE score ≥5, and SCA. High RE score remained a significant predictor of SCA independent of the echocardiographic LVH providing further evidence that electrical and anatomic LVH are somewhat distinct clinical entities. High RE score also appeared to be a better predictor than purely voltage-based criteria.
We also demonstrate that of the nine variables assessed in the RE score, SV 1-2 ≥ 30 mm and delayed intrinsicoid deflection remained significantly associated with SCA independent of anatomic LVH.
Increased LV mass has been previously established as a risk factor for SCA (Verdecchia et al., 1998) , but recent evidence suggests that electrocardiographic LVH is an additional risk factor for SCA with a potentially independent mechanism (Narayanan et al., 2014) . Our results support the concept that some patients have adverse, purely electrical LV remodeling as a phenomenon distinct from anatomic LVH.
In this study, we evaluated whether RE score which takes into account several ECG patterns associated with SCA, leads to the improved detection of SCA risk (Darouian et al., 2016; Teodorescu et al., 2001) .
LVH according to the RE score was associated with a greater than 2.5-fold risk of SCA, which was higher than with more widely used Sokolow-Lyon and Cornell criteria based purely on QRS amplitudes.
However, it is unlikely for this increase in risk to be secondary due to better detection of anatomic LVH as the kappa statistic, measuring agreement between electrocardiographic and echocardiographic diagnosis of LVH, was low.
When evaluating the individual components of the RE score in univariate analysis, five of the nine variables, namely strain pattern (with or without digoxin), deep S wave in V 1-2 , left atrial abnormality, and delayed intrinsicoid deflection, were found to be associated with SCA.
However, when anatomic LVH was included in the model, only SV 1-2 ≥ 30 mm and delayed intrinsicoid deflection remained significant predictors of SCA. The S wave in V 1-2 is a component of many ECG LVH criteria including both Sokolow-Lyon and the RE score (Romhilt & Estes, 1968; Sokolow & Lyon, 1949) , but there is little reported on the significance of the S wave in V 1-2 beyond its relationship with left ventricular hypertrophy. In contrast, the association between delayed intrinsicoid deflection and SCA has been recently described (Darouian et al., 2016) .
Strain was found to be associated with SCA, but this risk was not found to be independent of anatomic LVH in a multivariate model.
Strain pattern has been previously identified as a significant predictor of a wide range of clinical conditions including myocardial infarction, congestive heart failure, cardiovascular mortality, and sudden cardiac death (Kannel, Gordon, Castelli, & Margolis, 1970; Larsen et al., 2002; Okin et al., , 2006 Okin et al., , 2009 Pringle, Macfarlane, McKillop, Lorimer, & Dunn, 1989) . The pathophysiology behind strain has been proposed to be secondary to a wide spectrum of etiologies including myocardial hypertrophy, subendocardial ischemia, myocardial fibrosis, and alterations in conduction velocity with the precise mechanism not F I G U R E 1 Univariate odds ratio of SCA with ECG LVH criteria yet known (Anderson et al., 2000; Bacharova, Szathmary, & Mateasik, 2013; Devereux & Reichek, 1982; Eranti et al., 2014; Okin et al., 2006; Pringle et al., 1989; Rembert, Kleinman, Fedor, Wechsler, & Greenfield, 1978; Schocken, 2014; Shah et al., 2014) . However, based on this study, the adverse prognosis of strain seems to be associated with underlying structural cardiac pathology, and not to strain pattern per se. Left atrial abnormality on the 12-lead ECG has also been associated with poor cardiovascular outcomes including development of atrial fibrillation, congestive heart failure, and all-cause mortality (Eranti et al., 2014; Tereshchenko et al., 2014) , and in this study, it was associated with SCA in the univariate analysis. However, this finding lost statistical significance when included in multivariate analysis including left ventricular hypertrophy, suggesting a likely overlap between left atrial abnormality and anatomic LVH in the mechanism of SCA risk.
Beyond SCA, the RE score has been studied for its relationship with additional adverse clinical outcomes. Recently, reported that increasing RE scores were associated with greater risk of all-cause mortality. Definite LVH, or a score of ≥5 was found to have a greater than fourfold risk of mortality as compared to a score of 0 . In that study, it was also found that left atrial abnormality, QRS amplitude, ST changes consistent with strain pattern, and delayed intrinsicoid deflection were all independently predictive of allcause mortality . The RE score was also found to be predictive of cardiovascular events including coronary artery disease, congestive heart failure, and stroke , but anatomic LVH was not accounted for in this study.
Our community-based study design has some notable strengths including the prospective methods of ascertaining subjects for evaluation. Since CAD is responsible of the vast majority of SCA cases, we used a research design that included a majority of controls with CAD, which enabled us to evaluate differences between the two populations specific to SCA. However, the case-control approach also has certain inherent limitations. A large subset of the initial population was excluded from this study due to missing clinical variables, ECG, and echo information. These exclusions are expected, as studies such as echocardiography are not a part of routine medical care in subjects without cardiac risk factors. This does create a form of selection bias since those with echocardiographs performed prior to the SCA were more likely to have a cardiac history as compared to the excluded cases with no echocardiographs performed. An additional limitation of our study due to the number of excluded subjects is the relatively small subset of our population with strain present, and it is possible that with a larger sample size some further significant differences could have been found. The study was also limited in that more sensitive tools for assessing LV mass including cardiac MRI were not available for the diagnosis for anatomic LVH.
| CONCLUSION
Our findings demonstrate that definite LVH as defined by the RE point score system is associated with SCA independent of echocardiographic LVH. In comparison to other well-known ECG voltage-based LVH criteria, the RE score conferred higher risk of SCA. Of the individual variables of the RE score, two remained independent predictors of SCA independent of echocardiographic LVH. These results further support electrical remodeling occurring as an isolated phenomenon in some patients, also contributing to increased risk of SCA distinctively from anatomic LVH.
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